Biotech
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwire) -- 03/14/12 -- Cytovance® Biologics, a leading full-service contract manufacturer ("CMO") of mammalian and microbial biologics, strengthens its managemen ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 03/13/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced the pricing of its offering of $225 million aggregate principal amount of 2.625% convertible senior n ...
WATERTOWN, MA: WATERTOWN, MA -- (Marketwire) -- 03/13/12 -- Two novel autoantigen biomarkers for the autoimmune liver disease Primary Biliary Cirrhosis (PBC), discovered by AmberGen, Inc., in collaboration with th ...
BOSTON, MA: Service Leverages Practicing, Board-Certified, Sub Specialty-Trained Radiologists for Increased Patient Safety ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 03/13/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the ...
CARY, NC: PDUFA Goal Date of October 29, 2012 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 03/13/12 -- Abattis Biologix Corporation (the "Company" or "Abattis") (CNSX: FLU), is pleased to announce that further to its news ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/13/12 -- , the journal of pharmaceutical and biopharmaceutical contract services and a business unit of , today announced the launch of their newly redes ...
PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 03/13/12 -- DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V. (NYSE, Euronext: ...
RESEARCH TRIANGLE PARK, NC: RESEARCH TRIANGLE PARK, NC -- (Marketwire) -- 03/13/12 -- Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a sixth patent infringement laws ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 03/12/12 -- Medivation, Inc.(NASDAQ: MDVN) today announced its intention to offer, subject to market and other conditions, approximately $175 million principal a ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 03/12/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV) has signed a research agreement with Weill Cornell Me ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 03/12/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that an abstract describing the Company's Phase IIb study ev ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/12/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) announced that TH-302 will be featured among several presentations by academic and industry expe ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/12/12 -- , a leading digital marketplace for the life science industry and a business unit of , today announced they've appointed media executive Jo ...
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN -- (Marketwire) -- 03/12/12 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that it has posted Frequently Asked Questions on its website to pr ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 03/09/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV) today announced that pursuant to terms and conditions ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 03/09/12 -- Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) ("Bradmer" or the "Company") today announced its fourth quarter and fiscal year ...
TUSTIN, CA: Data From Seven Ongoing Bavituximab Clinical Trials Expected Throughout 2012 ...
TUSTIN, CA: Promising Progression-Free Survival From Site Assessments; Overall Survival Endpoint From This Study Anticipated in Second Half of 2012 ...
